Latest
By Staff Report / Wednesday, October 28th, 2015 / Banking & Finance, Banking Industry, Latest news, Tri-County Public Companies / Comments Off on Shareholders approve proposed American Riviera Bank and The Bank of Santa Barbara merger
American Riviera Bank and The Bank of Santa Barbara shareholders approved the banks’ proposed merger, the institutions announced on Oct. 27. The merger is expected to close by January 2016, pending final regulatory approval. The combined companies, which will go by American Riviera Bank, will have branches in downtown Santa Barbara, Montecito and Goleta Read More →
Read More →
Latest
By Philip Joens / Wednesday, October 28th, 2015 / Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies / Comments Off on Amgen’s third quarter earnings beat Wall Street expectations
Thousand Oaks biotech giant Amgen blew Wall Street away when it released third quarter earnings on Oct. 28. Amgen beat analyst revenue estimates by posting revenues of $5.72 billion, compared to the $5.23 billion analysts expected. That’s up from about $5 billion during last year’s third quarter. Net income increased to $1.86 billion during the Read More →
Read More →
Latest
By Philip Joens / Wednesday, October 28th, 2015 / Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies / Comments Off on Sientra CEO ducks questions about company’s future
Sientra CEO Hani Zeini said in a conference call on Oct. 28 that he will not speculate about the company’s future. Zeini dodged questions better than a Brooklyn Dodger dodges street cars during the call with investors, analysts and reporters to update all parties about implants contaminated by Sientra’s manufacturer. Sientra shares nosedived on Sept. Read More →
Read More →
Latest
By Staff Report / Tuesday, October 27th, 2015 / Earnings, Latest news / Comments Off on Inphi third quarter earnings beat analyst estimates
Inphi Corp. beat analyst estimates by a penny when the company released third quarter earnings on Oct. 27. The Santa Clara-based company, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. Inphi Corp. earnings were 25 cents per share, one cent greater Read More →
Read More →
Latest
By Staff Report / Tuesday, October 27th, 2015 / Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies / Comments Off on FDA OKs Amgen skin cancer drug Imlygic
The U.S. Food and Drug Administration on Oct. 27 approved Amgen’s cancer immunotherapy drug Imlygic for use in patients with the most deadly types of skin cancer. Imlygic, which is the first immunotherapy like this to gain approval for use in the U.S., is a genetically modified herpes virus that is designed to replicate itself Read More →
Read More →
